Type 2 diabetes mellitus, metabolic syndrome and change in lifestyle
Keywords:
body composition, diabetes mellitus, type 2, life style, intervention studies, metabolic syndromeAbstract
Type 2 diabetes mellitus promotes increased morbidity and mortality from cardiovascular diseases. These diseases have the same genetic components and environmental antecedents and insulin resistance is considered one of the main possible antecedents. The metabolic syndrome is a complex disorder represented by a set of cardiovascular risk factors that are commonly associated with central adiposity and insulin resistance. Changing inadequate feeding habits, losing weight and exercising regularly are considered first-choice therapies in treating the metabolic syndrome since they reduce waist circumference, visceral fat and plasma concentrations of glucose and triglycerides; they improve insulin sensitivity and increase HDL cholesterol; consequently, they
reduce the risk factors for type 2 diabetes mellitus and cardiovascular diseases. Thus, the objective of this article was to describe and analyze some of the main studies published in the last decades which showed that adopting a healthy lifestyle promotes the primary prevention of type 2 diabetes mellitus. An educational intervention that focuses on proper nutrition and exercise and, therefore, reduces the risk factors associated with metabolic syndrome and cardiovascular diseases, can help change inadequate lifestyles.
References
Sociedade Brasileira de Diabetes. Consenso Brasileiro sobre Diabetes 2002. Diagnóstico e classificação do diabetes melito e tratamento do diabetes melito tipo 2. São Paulo; 2003.
International Diabetes Federation. Diabetes health economics: facts, figures and Forecasts. Brussels: IDF; 1999.
Gross JL, Ferreira SRG, Franco LJ, Schmidt MI, Motta DG, Quintão E, et al. Diagnóstico e classificação do diabetes melito e tratamento do diabetes melito tipo 2. Recomendações da Sociedade Brasileira de Diabetes. Arq Bras Endocrinol Metabol. 2000; 44(4):Supl 1:8-35.
McLellan KCP, Motta DG, Lerario AC, Campino ACC. Custo do atendimento ambulatorial e gasto hospitalar do Diabetes Mellitus tipo 2. Saúde em Revista. 2006; 8(20):37-45.
Portero KCC, Motta DG, Campino, AAC. Abordagem econômica e fluxograma do atendimento a pessoas com Diabetes Mellitus tipo 2 na rede pública de saúde de um município paulista. Saúde em Revista. 2003; 5(11):35-42.
Portero KCC, Cattalini M. Mudança no estilo de vida para prevenção e tratamento do Diabetes Mellitus tipo 2. Saúde em Revista. 2005; 7(16): 63-9.
Franco LJ. Epidemiologia do Diabetes Mellitus. In: Lessa I. O adulto brasileiro e as doenças da modernidade: epidemiologia das doenças crônicas não transmissíveis. São Paulo: Hucitec; 1998. p.123-37.
American Diabetes Association. The prevention or delay of type 2 Diabetes. Diabetes Care. 2002; 25(4):742-9.
Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Cardiologia. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Arq Bras Cardiol. 2005; 84(Supl 1):1-28.
Ceriello A, Motz E. Is oxdative stress the patogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revised. Arterioscler Thromb Vasc Biol. 2004; 24(5):816-23.
Wajchenberg BL, Santomauro ATMG, Santos RF. Diabetes Melito insulino-dependente (Tipo II): diagnóstico, etiopatogenia e fisiopatologia. In: Wajchenberg BL, organizador. Tratado de endocrinologia clínica. São Paulo: Roca; 1992. p.706-38.
American Diabetes Association. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26(11):3160-7.
Report of the expert commitee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997; 20(7):1183-97.
Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years. Diabetes. 1987; 36(4):523-34.
Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis research group on the diagnosis of diabetes using glycated hemoglobin levels. JAMA. 1996; 276(15):1246-52.
The Expert Commitee on the Diagnosis on Classification of Diabetes Mellitus. Report of the expert commitee on the diagnosis on classification of diabetes mellitus. Diabetes Care. 2001; 24(Suppl 1):5-20.
Reaven GM. Banting Lecture: role of insulin resistance in human disease. Diabetes. 1988; 37(12): 1595-607.
Chandran M, Ciaraldi PSA, Henry R. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003; 26(8):2442-50.
Flier JS. The missing link with obesity? Nature. 2001; 409(6818):292-3.
Patane G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM. Role of ATP production and uncoupling protein-2 in insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of PPARg inhibition. Diabetes. 2002; 51(9):2749-56.
Esposito K, Pontillo A, Palo CD, Giuliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA. 2003; 289(14):1799-804.
Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of resamply suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002; 156(11):1070-7.
Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willet WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent-diabetes mellitus in women. JAMA. 1997; 277(20):472-7.
Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, et al. Dietary fiber, glycemic load and risk of NIDDM in men. Diabetes Care. 1997; 20(4):545-50.
Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, Folsom AR. Carbohydrates, dietary fiber, and incidence of type 2 diabetes in older women. Am J Clin Nutr. 2000; 71(4):921-30.
Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, et al. Dietary fat intake and risk of NIDDM in women. Am J Clin Nutr. 2001; 73(6): 1019-26.
Prentice AM, Jebb AS. Obesity in Britain: gluttony or sloth? BMJ. 1995; 311(7002):437-9.
Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet. 1991; 338(8770): 774-8.
Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical activity in predicting mortality among women. N Eng J Med. 2004; 351(26):2694-703.
Zimmet PZ, McCarty DJ, Courten MP. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications. 1997; 11(2):60-8.
Sartorelli DS, Franco LJ. Tendências do diabetes mellitus no Brasil: o papel da transição nutricional. Cad Saúde Pública. 2003; 19(Sup 1):29-36.
Sartor G, Schersten B, Carlstrom S, Melander A, Norden A, Persson G. Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes. 1980; 29(1):41-9.
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002; 359(9323): 2072-7.
Pan XR, Li GW, Wang WY, An ZX, Hu ZX, Lin J, et al. Effect of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997; 20(4):537-44.
Eriksson KF, Lindgärde R. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia. 1991; 34(12):891-8.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med. 2001; 344 (18):1343-50.
Knowler WC, Barret-Connor E, Fowler SF, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Eng J Med. 2002; 346(6):393-403.
Bourn DM, Mann JI, McSkimming BJ, Waldron MA, Wishart JD. Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect? Diabetes Care. 1994; 17(11):1311-9.
Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. Xenical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care. 2004; 27(1):155-61.
Hu FB, Manson JE, Stampfer MJ, Colditz G, Lui S, Solomon C, et al. Diet, Lifestyle, and the risk of tipe 2 diabetes mellitus in woman. N Eng J Med. 2001; 345(11):790-7.
Melin I, Karlström B, Lappalainen R, Berglund L, Mohsen R, Vessby B. A programme of behavior modification and nutritional counseling in the treatment of obesity: a randomized 2-y clinical trial. Int J Obes. 2003; 27(9):1127-35.
McAuley KA, Williams SM, Mann JI, Goulding A, Chisholm A, Wilson N, et al. Intensive lifestyle changes are necessary to improve insulin sensitivity. Diabetes Care. 2002; 25(3):445-52.
Balkestein EJ, van Aggel-Leijssen DP, van Baak MA, Struijker-Boudier HA, van Bortel LM. The effect of weight loss with or without exercise training on large artery compliance in healthy obese men. Hypertension. 1999; 17:1831-5.
Lavrencic A, Salobir BG, Keber I. Physical training improves flow-mediated dilatation in patientes with the polymetabolic syndrome. Arterioscler Thromb Vasc Biol. 2000; 20(2):551-5.
Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care. 2003; 26(7):2119-25.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Kátia Cristina Portero McLELLAN, Sandra Maria BARBALHO, Marino CATTALINI, Antonio Carlos LERARIO
This work is licensed under a Creative Commons Attribution 4.0 International License.
